Tailored NEOadjuvant epirubicin, cyclophosphamide and Nanoparticle Albumin-Bound paclitaxel for breast cancer: The phase II NEONAB trial—Clinical outcomes and molecular determinant...

por Murphy, Caitlin, Muscat, Andrea, Ashley, David, Mukaro, Violet, West, Linda, Liao, Yang, Chisanga, David, Shi, Wei, Collins, Ian, Baron-Hay, Sally, Patil, Sujata, Lindeman, Geoffrey, Khasraw, Mustafa
Publicado 2019